Receptor tyrosine kinases (RTKs) are key mediators of signal transmission in response to extracellular cues that regulate cell proliferation and differentiation. A ubiquitous and highly conserved route by which RTKs initiate signals that control cell growth is through the activation of the small genuine nucleotide binding protein Ras. Specific and precise signaling by the RTK-Ras pathway requires that both the intensity and duration of the elicited intracellular signals be tightly regulated, and disruption of this regulation is intimately linked to the loss of growth control displayed by cancer cells. The broad objective of this research project is to define the molecular mechanisms that control signaling dynamics by RTKs. The studies outlined in this application are aimed at determining how the signaling output of the RTK-Ras pathway is balanced through positive and negative modulation. The proposed experiments will focus on two signaling events that are central to the regulation of RTK-Ras pathway: (1) Sos-mediated Ras activation will be used as a prototype for the positive regulation of the pathway. (2) Sprouty-mediated inhibition of RTK-Ras signaling will be used as a prototype for the negative regulation of the pathway. Genetic, biochemical and cell biological approaches will be used to pursue the following specific aims: 1. To define the molecular mechanisms of Ras activation by Sos 2. To establish the significance of inter- and intra-molecular interactions for Sos function. 3. To determine the role of Sprouty in the regulation of RTK-Ras signaling. Collectively, the experiments proposed herein will provide new insights into the molecular mechanisms that determine the levels of activity of the RTK-Ras pathway. As such, these studies will advance our understanding of cellular processes that control cell growth and the nature of their subversion in cancer cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA028146-21A1
Application #
6542631
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1980-08-01
Project End
2006-06-30
Budget Start
Budget End
Support Year
21
Fiscal Year
2001
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Feres, Kimberly J; Hayman, Michael J (2010) RON-expressing MCF-10A breast epithelial cells exhibit alterations of hyaluronan expression, promoting RON-mediated early adhesion events. Biochem Biophys Res Commun 391:1604-9
Feres, K J; Ischenko, I; Hayman, M J (2009) The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells. Oncogene 28:279-88
Yoo, Jae Cheal; Hayman, Michael J (2007) Annexin II binds to SHP2 and this interaction is regulated by HSP70 levels. Biochem Biophys Res Commun 356:906-11
Tartaglia, Marco; Pennacchio, Len A; Zhao, Chen et al. (2007) Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39:75-9
Reich, Nancy C (2007) STAT dynamics. Cytokine Growth Factor Rev 18:511-8
Yondola, Mark A; Hearing, Patrick (2007) The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha. J Virol 81:4264-71
Ullman, Amanda J; Reich, Nancy C; Hearing, Patrick (2007) Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol 81:4744-52
Zhao, Chen; Du, Guangwei; Skowronek, Karl et al. (2007) Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 9:706-12
Kim, Hong Joo; Taylor, Laura J; Bar-Sagi, Dafna (2007) Spatial regulation of EGFR signaling by Sprouty2. Curr Biol 17:455-61
Merritt, Rebecca; Hayman, Michael J; Agazie, Yehenew M (2006) Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant. Biochim Biophys Acta 1763:45-56

Showing the most recent 10 out of 281 publications